Gasdermin D emerges as a potential therapeutic target for atrial fibrillation
This study reveals that gasdermin D plays a novel role in the development of atrial fibrillation through multifaceted mechanisms.
Read More
atrial fibrillation
Reduced levels of FKBP5 promote atrial fibrillation
These studies point to FKBP5 as a potential novel target for the treatment of this life-threatening condition.
Read More
The Cardiovascular Research Institute 8th Annual Symposium
Review the symposium highlights, visit the virtual poster session and meet the winners of the first Dr. Mark L. Entman Award for Excellence in Cardiovascular Education.
Read More
Novel mechanism connects SPEG, RyR2 and atrial fibrillation
Reduced levels of protein kinase SPEG lead to hyperactive calcium channel RyR2 and an increased risk of atrial fibrillation.
Read More
What’s at the ‘heart’ of a heartbeat?
In the confines of the thoracic chamber, a heart has lost its rhythm. Its two upper chambers, the atria, are beating out of sync with
Read More